The rapid microbiology tests market was valued at USD 12.03 Bn in 2015,
and is expected to reach USD 19.50 Bn by 2022, expanding at a CAGR of 6%
from 2016 to 2022.

Rapid microbiological tests are gaining momentum in the global market as
a reliable and cost-effective method to track and monitor all types of
microorganisms in clinical as well as industrial settings. In addition,
rapid microbiology tests offer faster and more accurate methods to
assist in the rapid diagnosis and treatment of patients or to provide
safe and reliable food, water, and pharmaceuticals. North America held
the largest regional market, accounting for the market share of over 33%
in 2015, and is anticipated to dominate the global rapid microbiology
tests market during the forecast period 2016 to 2022. Large numbers of
market-focused players providing wider range of product portfolio are
the key to growth of the North America region.

Asia Pacific is expected to grow at a highest growth rate during the
focus period, due to increase in the number of laboratories in these
regions and up gradation of existing ones for automation of various
instrumentation systems. Moreover, the market is wide open for advancing
rapid diagnostic technologies to improve patient management, exponential
population growth and aging conventional technology will only intensify
the pace of development in the region.